Latest Breaking News On - Triterpenoid antifungals - Page 1 : comparemela.com

SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update

SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaTriterpenoid antifungalsNathan wiederholdIrina kofflerDavid anguloScynexis incNational institute of healthExchange commissionEuropean society of clinical microbiologyDrug administrationPreclinical development programChief executiveNational instituteEuropean societyClinical microbiologyInfectious diseases

SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update

SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaNathan wiederholdIrina kofflerTriterpenoid antifungalsDavid anguloEuropean society of clinical microbiologyExchange commissionDrug administrationScynexis incGlobe newswire scynexis incPreclinical development programNational institute of healthFirst quarterProvides corporateChief executiveNational institute

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

David anguloHansoh pharmaRelationsirina kofflerlifesci advisorstelTriterpenoid antifungalsScynexis incDrug administrationExchange commissionCongress on trends in medical mycologyPreclinical development programGlobe newswire scynexis incHansoh pharmaceutical group companyChief executive officerHansoh pharmaceutical group company limitedNew drug applicationMedical mycologyGreece october

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Triterpenoid antifungalsHansoh pharmaDavid anguloIrina kofflerCongress on trends in medical mycologyExchange commissionPreclinical development programHansoh pharmaceutical group companyScynexis incGlobe newswire scynexis incDrug administrationThird quarterProvides corporateChief executive officerHansoh pharmaceutical group company limitedNew drug application

SCYNEXIS Reports Second Quarter 2023 Financial Results and Provides Corporate Update

SCYNEXIS reported the closing of an exclusive license agreement with GSK for BREXAFEMME® (Ibrexafungerp Tablets). SCYNEXIS received an upfront pay.

Irina kofflerDavid anguloHansoh pharmaTriterpenoid antifungalsPreclinical development programEuropean congressExchange commissionGlobe newswire scynexis incChina national medical products administrationHansoh pharmaceutical group companyDrug administrationScynexis incIbrexafungerp tabletsNew drug applicationNational medical products administrationChief executive officer